Peripheral edema due to increased vascular permeability: a clinical appraisal
- 1 June 1992
- journal article
- research article
- Published by Springer Nature in International Journal of Clinical and Laboratory Research
- Vol. 21 (2-4) , 241-246
- https://doi.org/10.1007/bf02591654
Abstract
The release of vasoactive substances produces reversible changes of endothelial permeability with consequent edematous syndromes. We present 899 patients referred to our clinic for “non-hydrostatic non-hyponcotic” recurrent edema problems. Personal and family histories were recorded and a complete physical examination was carried out for each patient. In chronic situations laboratory tests [blood cell count, cryoglobulins, thyroid hormones, complement components (C3, C4, C1 inhibitor), total IgE, skin testing] were performed. Four subgroups of angioedema are identified for relevant clinical and etiopathogenetic differences. Seventy-three percent of patients had an urticaria-angioedema syndrome responding to antihistamine and/or corticosteroid treatment (histamine-dependent angioedema). Twenty-three percent had an angioedema related to a deficiency in C1 esterase inhibitor (complement-dependent angioedema). In a minority of patients, angioedema was due to the pharmacological effect of a drug (pharmacological angioedema) or was of a totally unknown origin (idiopathic angioedema). A generalized increase in vascular permeability was reported in 3 patients (systemic capillary leak syndrome). A brief survey of the literature is given with the review of our patients.Keywords
This publication has 40 references indexed in Scilit:
- The Systemic Capillary Leak Syndrome: Appearance of Interleukin-2-Receptor-Positive Cells during AttacksAnnals of Internal Medicine, 1990
- Identification of a new P1 residue mutation (444Arg→Ser) in a dysfunctional C1 inhibitor protein contained in a type II hereditary angioedema plasmaFEBS Letters, 1990
- Studies of the mechanism of angiotensin-converting enzyme (ACE) inhibitor-associated angioedema: The effect of an ACE inhibitor on cutaneous responses to bradykinin, codeine, and histamineJournal of Allergy and Clinical Immunology, 1990
- Inherited CI Inhibitor DeficiencyComplement and Inflammation, 1989
- Type I C1 inhibitor deficiency with a small messenger RNA resulting from deletion of one exon.Journal of Clinical Investigation, 1989
- Therapy of chronic idiopathic urticaria with nifedipine: Demonstration of beneficial effect in a double-blinded, placebo-controlled, crossover trialJournal of Allergy and Clinical Immunology, 1989
- Restriction fragment length polymorphism of the C1 inhibitor gene in hereditary angioneurotic edema.Journal of Clinical Investigation, 1987
- Autoantibody-Mediated Acquired Deficiency of C1 InhibitorNew England Journal of Medicine, 1987
- Molecular basis for the deficiency of complement 1 inhibitor in type I hereditary angioneurotic edema.Journal of Clinical Investigation, 1987
- Human C.hivin.1 inhibitor: primary structure, cDNA cloning, and chromosomal localizationBiochemistry, 1986